Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3392482 | Transplant Immunology | 2007 | 4 Pages |
Abstract
Increasing evidence suggests that there may be a causal relationship between the development of donor-specific alloantibodies and chronic allograft vasculopathy (CAV). PVG.RT1u rat heart allografts spontaneously undergo chronic rejection when transplanted into unmodified PVG.R8 congenic recipients that differ only at the classical MHC class I RT1.A locus. Here we show that development of vasculopathy in this experimental model is associated with production of a strong anti-Au antibody response. Perioperative intravenous administration of recombinant soluble RT1.Au heavy chain that is sequence identical to donor MHC class I, or chimaeric Au/a (donor/recipient) protein had a variable effect resulting generally in either sensitisation and accelerated rejection, or abrogation of alloantibody and attenuation of chronic rejection. These findings highlight the potential for soluble donor MHC class I alloantigen given at the time of heart transplantation to influence alloantibody production and graft outcome.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Alistair J. Easterfield, Luc Delriviere, Margaret S. Wallduck, Sivasuriya Sivaganesh, J. Andrew Bradley, Eleanor M. Bolton,